Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Lidocaine Hydrochloride (Xylocaine) Injection
Status: Currently in Shortage
»Date first posted:
02/22/2012
»Therapeutic Categories: Anesthesia; Pediatric
American Regent/Luitpold (Reverified 03/30/2021)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1%, 50 mL vial package of 25 (NDC 00517-0625-25) | Unavailable-No product available for release. No plan to manufacture. | Discontinuation of the manufacture of the drug |
Amphastar Pharmaceuticals, Inc./IMS (Reverified 08/12/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2%, 5mL Luer-Jet Prefilled Syringe (NDC 76329-3390-1)(old NDC 0548-3390-00) | Backordered due to the increase in demands | Demand increase for the drug |
Eugia Pharma Specialties LTD. (formerly Aurobindo) (Reverified 08/12/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2% MDV 1000mg/50mL (NDC 55150-256-50) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 1% 2 mL Ampoule (NDC 55150-158-72) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 1% 5 mL Ampoule (NDC 55150-159-74) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 2% 2 mL Ampoule (NDC 55150-160-72) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 1% 2 mL Single Dose Vial (NDC 55150-161-02) | Currently on backorder - next shipment anticipated Mid July | Demand increase for the drug | |
| 1% 5 mL Single Dose Vial (NDC 55150-162-05) | Currently on backorder - next shipment anticipated Late July | Demand increase for the drug | |
| 1% 30 mL Single Dose Vial (NDC 55150-163-30) | Currently on backorder - next shipment anticipated Late Aug | Demand increase for the drug | |
| 2% 2 mL Single Dose Vial (NDC 55150-164-02) | Currently on backorder - next shipment anticipated Late Aug | Demand increase for the drug | |
| 2% 5 mL Single Dose Vial (NDC 55150-165-05) | Currently on backorder - next shipment Mid July | Demand increase for the drug | |
| 1% 10 mL Multi Dose Vial (NDC 55150-251-10) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 1% 20 mL Multi Dose Vial (NDC 55150-252-20) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 2% 10 mL Multi Dose Vial (NDC 55150-254-10) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 2% 20 mL Multi Dose Vial (NDC 55150-255-20) | Currently on backorder - next shipment anticipated Mid July | Demand increase for the drug |
Fresenius Kabi USA, LLC (Revised 09/14/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97) | Backordered. Next release not available at this time. | Demand increase for the drug | |
| Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91) | Backordered. Next release not available at this time. | Check wholesalers for inventory. | Demand increase for the drug |
| Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02) | Backordered. Next release September 2022. | Check wholesalers for inventory. | Demand increase for the drug |
| Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05) | Backordered. Next release September 2022. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17) | Backordered. Next release October 2022. | Demand increase for the drug | |
| Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27) | Backordered. Next release October 2022. | Demand increase for the drug | |
| Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57) | Backordered. Next release not available at this time. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10)discontinued | Not available at this time. | Demand increase for the drug | |
| Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued | Not available at this time. | Demand increase for the drug | |
| Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50)-NDC discontinued | Not available at this time. | Demand increase for the drug | |
| Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27) | Backordered. Next release not available at this time. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07) | Backordered. Next release November 2022. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97) | Backordered. Next release date not available at this time. | Check wholesalers for inventory. | Demand increase for the drug |
| Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57) | Not available at this time. | Demand increase for the drug | |
| Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57) | Backordered. Next release not available at this time. | Check wholesalers for inventory. | Demand increase for the drug |
| Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02) | Backordered. Next release October 2022. | Check wholesalers for inventory. | Demand increase for the drug |
| Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10) | Backordered. Next release September 2022. | Demand increase for the drug | |
| Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27) | Backordered. Next release October 2022. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57) | Backordered. Next release October 2022. | Demand increase for the drug | |
| Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27) | Backordered. Next release September 2022. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80) | Not available at this time. | Demand increase for the drug | |
| Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89) | Not available at this time. | Demand increase for the drug | |
| Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57) | Backordered. Next release November 2022. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37) | Backordered. Next release October 2022. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31) | Not available at this time. | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 08/26/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1% 5 mL vial, Preservative Free (NDC 0143-9595-25) | This presentation is temporarily on backorder. | Demand increase for the drug | |
| 2% 5 mL vial, Preservative Free (NDC 0143-9594-25) | This presentation is temporarily on backorder. | Demand increase for the drug | |
| 1% 50 mL vial, Preserved (NDC 0143-9577-10) | This presentation is temporarily on backorder. | Demand increase for the drug | |
| 2% 50 mL vial, Preserved (NDC 0143-9575-10) | This presentation is temporarily on backorder. | Demand increase for the drug |
Hospira, Inc. (Revised 09/12/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 300 mg/20 mL (1.5%; 15 mg/mL); Glass Ampul (NDC 0409-4776-01) | Next Delivery and Estimated Recovery: September 2022 | Demand increase for the drug | |
| 50 mg/5 mL (1%; 10 mg/mL); Ansyr Plastic Syringe (NDC 0409-9137-05) | Next Delivery: November 2022; Estimated Recovery: December 2022 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 20 mg/2 mL (1%; 10 mg/mL); Glass Ampul (NDC 0409-4713-32) | Next Delivery: September 2022; Estimated Recovery: November 2022 | Demand increase for the drug | |
| 200 mg/20 mL (1%; 10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-01, pack of 25; NDC 0409-4276-16, individual) | Next Delivery: September 2022; Estimated Recovery: February 2023 | Demand increase for the drug | |
| 300 mg/30 mL (1%; 10 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4279-02) | Next Delivery: November 2022; Estimated Recovery: June 2023 | Demand increase for the drug | |
| 500 mg/50 mL (1%; 10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-02; NDC 0409-4276-17, individual) | Next Delivery: October 2022; Estimated Recovery: June 2023 | Demand increase for the drug | |
| 40 mg/2 mL (2%; 20 mg/mL); Glass Ampul (NDC 0409-4282-01) | Next Delivery: September 2022; Estimated Recovery: October 2022 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 200 mg/10 mL (2%; 20 mg/mL); Glass Ampul (NDC 0409-4282-02) | Next Delivery: September 2022; Estimated Recovery: February 2023 | Demand increase for the drug | |
| 50 mg/5 mL (1%; 10 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4904-34) | Available | Other | |
| 100 mg/5 mL (2%; 20 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4903-34) | Limited Supply Available. Next Delivery: September 2022; Estimated Recovery: November 2022 | Shortage per Manufacturer: Manufacturing Delay | Other |
| 100 mg/5 mL (2%; 20 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-2066-05) | Next Delivery: October 2022; Estimated Recovery: March 2023 | Demand increase for the drug | |
| 400 mg/20 mL (2%; 20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-01, pack of 25; NDC 0409-4277-16, individual) | Limited Supply Available. Next Delivery: January 2023; Estimated Recovery: March 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
| 1,000 mg/50 mL (2%; 20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-02) | Next Delivery and Estimated Recovery: October 2022 | Demand increase for the drug | |
| 200 mg/5 mL (4%; 40 mg/mL); Glass Ampul (NDC 0409-4283-01) | Next Delivery: November 2022; Estimated Recovery: January 2023 | Demand increase for the drug | |
| Xylocaine Cardiac 100 mg/5 mL (2%; 20 mg/mL); Ansyr Plastic Syringe (NDC 0409-1323-05) | Next Delivery: September 2022; Estimated Recovery: December 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 250 mg/50 mL (0.5%; 5 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4275-01) | Next Delivery: April 2023; Estimated Recovery: June 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 100 mg/2 mL (5%; 50 mg/mL) and 7.5% Dextrose; Glass Ampul (NDC 0409-4712-01) | Discontinued | Discontinuation of the manufacture of the drug | |
| 250 mg/50 mL (0.5%; 5 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4278-01) | Next Delivery: November 2022; Estimated Recovery: June 2023 | Demand increase for the drug | |
| 50 mg/5 mL (1%; 10 mg/mL); Glass Ampul (NDC 0409-4713-02) | Next Delivery: October 2022; Estimated Recovery: November 2022 | Demand increase for the drug |
Huons Co., Ltd. (South Korea) (New 09/06/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Methylparaben Free Lidocaine HCl Injection, USP 1% 50mg/5mL (Vial) (NDC 73293-0001-2) | Available | Demand increase for the drug |
Spectra Medical Devices, Inc. (Revised 01/07/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1% 5 mL ampule (NDC 65282-1605-1) | Available | Other |